Have a personal or library account? Click to login
High Rates of Uncontrolled Blood Pressure in Malawian Adults Living with HIV and Hypertension Cover

High Rates of Uncontrolled Blood Pressure in Malawian Adults Living with HIV and Hypertension

Global Heart
Volume 16 (2021): Issue 1
By: Risa M. Hoffman,  Florence Chibwana,  Daniel Kahn,  Ben Allan Banda,  Linna Phiri,  Mayamiko Chimombo,  Chiulemu Kussen,  Hitler Sigauke,  Agnes Moses,  Joep J. van Oosterhout,  Sam Phiri,  Jesse W. Currier,  Judith S. Currier and  Corrina Moucheraud  
Open Access
|Dec 2021

References

  1. 1Bigna JJ, Noubiap JJ. The rising burden of non-communicable diseases in sub-Saharan Africa. Lancet Glob Health. 2019; 7(10): e1295–e6. DOI: 10.1016/S2214-109X(19)30370-5
    Back to article
  2. 2World Health Organization. Noncommunicable Diseases; 2021. Retrieved from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. (accessed 17 January 2021).
    Back to article
  3. 3Anand SS, Hawkes C, de Souza RJ, et al. Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System: A Report From the Workshop Convened by the World Heart Federation. J Am Coll Cardiol. 2015; 66(14): 1590–614. DOI: 10.1016/j.jacc.2015.07.050
    Back to article
  4. 4World Health Organization, Regional Office for Africa. Noncommunicable Diseases: Overview. n.d. Retrieved from: https://www.afro.who.int/health-topics/noncommunicable-diseases (accessed 19 January 2021).
    Back to article
  5. 5Feinstein MJ, Hsue PY, Benjamin LA, et al. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. Circulation. 2019; 140(2): e98–e124. DOI: 10.1161/CIR.0000000000000695
    Back to article
  6. 6So-Armah K, Benjamin LA, Bloomfield GS, et al. HIV and cardiovascular disease. Lancet HIV. 2020; 7(4): e279–e93. DOI: 10.1016/S2352-3018(20)30036-9
    Back to article
  7. 7Coetzee L, Bogler L, De Neve JW, et al. HIV, antiretroviral therapy and non-communicable diseases in sub-Saharan Africa: Empirical evidence from 44 countries over the period 2000 to 2016. J Int AIDS Soc. 2019; 22(7): e25364. DOI: 10.1002/jia2.25364
    Back to article
  8. 8Achwoka D, Waruru A, Chen TH, et al. Noncommunicable disease burden among HIV patients in care: A national retrospective longitudinal analysis of HIV-treatment outcomes in Kenya, 2003–2013. BMC Public Health. 2019; 19(1): 372. DOI: 10.1186/s12889-019-6716-2
    Back to article
  9. 9Haacker M, Barnighausen T, Atun R. HIV and the growing health burden from noncommunicable diseases in Botswana: Modelling study. J Glob Health. 2019; 9(1): 010428. DOI: 10.7189/jogh.09.010428
    Back to article
  10. 10Antiretroviral Therapy Cohort C. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies. Lancet HIV. 2017; 4(8): e349–e56. DOI: 10.1016/S2352-3018(17)30066-8
    Back to article
  11. 11Kwarisiima D, Balzer L, Heller D, et al. Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda. PLoS One. 2016; 11(5): e0156309. DOI: 10.1371/journal.pone.0156309
    Back to article
  12. 12Muronya W, Sanga E, Talama G, Kumwenda JJ, van Oosterhout JJ. Cardiovascular risk factors in adult Malawians on long-term antiretroviral therapy. Trans R Soc Trop Med Hyg. 2011; 105(11): 644–9. DOI: 10.1016/j.trstmh.2011.07.016
    Back to article
  13. 13Divala OH, Amberbir A, Ismail Z, et al. The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences for integrated services. BMC Public Health. 2016; 16(1): 1243. DOI: 10.1186/s12889-016-3916-x
    Back to article
  14. 14Kwarisiima D, Atukunda M, Owaraganise A, et al. Hypertension control in integrated HIV and chronic disease clinics in Uganda in the SEARCH study. BMC Public Health. 2019; 19(1): 511. DOI: 10.1186/s12889-019-6838-6
    Back to article
  15. 15Patel P, Speight C, Maida A, et al. Integrating HIV and hypertension management in low-resource settings: Lessons from Malawi. PLoS Med. 2018; 15(3): e1002523. DOI: 10.1371/journal.pmed.1002523
    Back to article
  16. 16Ministry of Health, Malawi. Malawi Guidelines for Clinical Management of HIV in Children and Adults, 3rd edition. 2016. Retrieved from: https://www.childrenandaids.org/sites/default/files/2017-04/Malawi_Clinical-HIV-Guidelines_2016.pdf. (accessed 17 January 2021).
    Back to article
  17. 17Ministry of Health, Malawi. Malawi Standard Treatment Guidelines, 5th edition. 2015. Retrieved from: https://extranet.who.int/ncdccs/Data/MWI_D1_Malawi-Standard-Treatment-Guidelines-Essential-Medicines-List-2015.pdf. (accessed 17 January 2021).
    Back to article
  18. 18Msyamboza KP, Kathyola D, Dzowela T, Bowie C. The burden of hypertension and its risk factors in Malawi: Nationwide population-based STEPS survey. Int Health. 2012; 4(4): 246–52. DOI: 10.1016/j.inhe.2012.09.005
    Back to article
  19. 19Magande PN, Chirundu D, Gombe NT, Mungati M, Tshimanga M. Determinants of uncontrolled hypertension among clients on anti-retroviral therapy in Kadoma City, Zimbabwe, 2016. Clin Hypertens. 2017; 23: 14. DOI: 10.1186/s40885-017-0070-4
    Back to article
  20. 20Sarfo FS, Mobula L, Plange-Rhule J, et al. Longitudinal control of blood pressure among a cohort of Ghanaians with hypertension: A multicenter, hospital-based study. J Clin Hypertens (Greenwich). 2020; 22(6): 949–58. DOI: 10.1111/jch.13873
    Back to article
  21. 21Hing M, Hoffman RM, Seleman J, et al. ‘Blood pressure can kill you tomorrow, but HIV gives you time’: illness perceptions and treatment experiences among Malawian individuals living with HIV and hypertension. Health Policy Plan. 2019; 34(Supplement_2): ii36–ii44. DOI: 10.1093/heapol/czz112
    Back to article
  22. 22Weiss JJ, Konstantinidis I, Boueilh A, et al. Illness Perceptions, Medication Beliefs, and Adherence to Antiretrovirals and Medications for Comorbidities in Adults With HIV Infection and Hypertension or Chronic Kidney Disease. J Acquir Immune Defic Syndr. 2016; 73(4): 403–10. DOI: 10.1097/QAI.0000000000001075
    Back to article
  23. 23Haas AD, Radin E, Hakim AJ, et al. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): Results from population-based nationally representative surveys. J Int AIDS Soc. 2020; 23(11): e25631. DOI: 10.1002/jia2.25631
    Back to article
  24. 24Moucheraud C, Hing M, Seleman J, et al. Integrated care experiences and out-of-pocket expenditures: A cross-sectional survey of adults receiving treatment for HIV and hypertension in Malawi. BMJ Open. 2020; 10(2): e032652. DOI: 10.1136/bmjopen-2019-032652
    Back to article
  25. 25Hyle EP, Naidoo K, Su AE, El-Sadr WM, Freedberg KA. HIV, tuberculosis, and noncommunicable diseases: What is known about the costs, effects, and cost-effectiveness of integrated care? J Acquir Immune Defic Syndr. 2014; 67(Suppl 1): S87–95. DOI: 10.1097/QAI.0000000000000254
    Back to article
  26. 26Sando D, Kintu A, Okello S, et al. Cost-effectiveness analysis of integrating screening and treatment of selected non-communicable diseases into HIV/AIDS treatment in Uganda. J Int AIDS Soc. 2020; 23 Suppl 1: e25507. DOI: 10.1002/jia2.25507
    Back to article
  27. 27Osetinsky B, Genberg BL, Bloomfield GS, et al. Hypertension Control and Retention in Care Among HIV-Infected Patients: The Effects of Co-located HIV and Chronic Noncommunicable Disease Care. J Acquir Immune Defic Syndr. 2019; 82(4): 399–406. DOI: 10.1097/QAI.0000000000002154
    Back to article
  28. 28Muddu M, Tusubira AK, Sharma SK, et al. Integrated Hypertension and HIV Care Cascades in an HIV Treatment Program in Eastern Uganda: A Retrospective Cohort Study. J Acquir Immune Defic Syndr. 2019; 81(5): 552–61. DOI: 10.1097/QAI.0000000000002067
    Back to article
  29. 29Nayyar GML, Breman JG, Herrington JE. The global pandemic of falsified medicines: Laboratory and field innovations and policy perspectives. Am J Trop Med Hyg. 2015; 92(6 Suppl): 2–7. DOI: 10.4269/ajtmh.15-0221
    Back to article
  30. 30Schafermann S, Hauk C, Wemakor E, et al. Substandard and Falsified Antibiotics and Medicines against Noncommunicable Diseases in Western Cameroon and Northeastern Democratic Republic of Congo. Am J Trop Med Hyg. 2020; 103(2): 894–908. DOI: 10.4269/ajtmh.20-0184
    Back to article
  31. 31Twagirumukiza M, Cosijns A, Pringels E, et al. Influence of tropical climate conditions on the quality of antihypertensive drugs from Rwandan pharmacies. Am J Trop Med Hyg. 2009; 81(5): 776–81. DOI: 10.4269/ajtmh.2009.09-0109
    Back to article
  32. 32Mapesi H, Gupta R, Wilson HI, et al. The coArtHA trial-identifying the most effective treatment strategies to control arterial hypertension in sub-Saharan Africa: Study protocol for a randomized controlled trial. Trials. 2021; 22(1): 77. DOI: 10.1186/s13063-021-05023-z
    Back to article
DOI: https://doi.org/10.5334/gh.1081 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: Nov 2, 2021
Accepted on: Oct 29, 2021
Published on: Dec 6, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
hypertension,
hypertension control,
HIV,
antiretroviral therapy,
adherence,
noncommunicable diseases

© 2021 Risa M. Hoffman, Florence Chibwana, Daniel Kahn, Ben Allan Banda, Linna Phiri, Mayamiko Chimombo, Chiulemu Kussen, Hitler Sigauke, Agnes Moses, Joep J. van Oosterhout, Sam Phiri, Jesse W. Currier, Judith S. Currier, Corrina Moucheraud, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 16 (2021): Issue 1Next article